MicroVision, Inc.
9.5.2024 22:07:59 CEST | ACCESS Newswire | Press release
REDMOND, WA / ACCESSWIRE / May 9, 2024 / MicroVision, Inc. (NASDAQ:MVIS), a leader in MEMS-based solid-state automotive lidar and ADAS solutions, today announced its first quarter 2024 results.
Key Business Highlights for Q1 2024
- Actively engaged in high-volume, top-tier global OEM RFQs for passenger vehicles.
- Expanding near-term revenue opportunities through direct sales in industrial markets.
- Working to accumulate non-dilutive cash by leveraging partnerships and licensing opportunities.
- Increasing cash runway through proactive, disciplined fiscal management.
"Energized by global OEM feedback that MicroVision offers the best technical and commercial solutions, we remain confident in our engagement with automotive OEMs and our prospects in high-volume, top-tier, passenger-vehicle RFQs," said Sumit Sharma, MicroVision's Chief Executive Officer. "As we navigate current headwinds in the automotive industry and lidar sector with a healthy balance of optimism and realism, we are aggressively pursuing near-term revenue opportunities in industrial markets and with partnership opportunities, as well as continuing our ethos of fiscal discipline."
"I remain committed to steering MicroVision and firmly establishing it as a leading automotive OEM supplier of lidar hardware and software solutions," continued Sharma.
Key Financial Highlights for Q1 2024
- Revenue for the first quarter of 2024 was $1.0 million, compared to $0.8 million for the first quarter of 2023 primarily driven by sales of MOVIA sensors to a global commercial trucking OEM.
- Net loss for the first quarter of 2024 was $26.3 million, or $0.13 per share, which includes $3.7 million of non-cash, share-based compensation expense, compared to a net loss of $19.0 million, or $0.11 per share, which includes $2.9 million of non-cash, share-based compensation expense, for the first quarter of 2023.
- Adjusted EBITDA for the first quarter of 2024 was a $18.7 million loss, compared to a $15.7 million loss for the first quarter of 2023.
- Cash used in operations in the first quarter of 2024 was $20.8 million, compared to cash used in operations in the first quarter of 2023 of $13.5 million.
- The Company ended the first quarter of 2024 with $73.1 million in cash and cash equivalents including investment securities, compared to $73.8 million at December 31, 2023.
Conference Call and Webcast: Q1 2024 Results
MicroVision will host a conference call and webcast, consisting of prepared remarks by management, a slide presentation, and a question-and-answer session at 1:30 PM PT/4:30 PM ET on Thursday, May 9, 2024 to discuss the financial results and provide a business update. Analysts and investors may pose questions to management during the live webcast on May 9, 2024.
The live webcast and slide presentation can be accessed on the Company's Investor Relations website under the Events tab at https://ir.microvision.com/events. The webcast will be archived on the website for future viewing.
About MicroVision
With offices in the U.S. and Germany, MicroVision is a pioneering company in MEMS-based laser beam scanning technology that integrates MEMS, lasers, optics, hardware, algorithms and machine learning software into its proprietary technology to address existing and emerging markets. The Company's integrated approach uses its proprietary technology to provide automotive lidar sensors and solutions for advanced driver-assistance systems (ADAS) and for non-automotive applications including industrial, smart infrastructure and robotics. The Company has been leveraging its experience building augmented reality micro-display engines, interactive display modules, and consumer lidar modules.
For more information, visit the Company's website at www.microvision.com, on Facebook at www.facebook.com/microvisioninc, and LinkedIn at https://www.linkedin.com/company/microvision/.
MicroVision, MAVIN, MOSAIK, and MOVIA are trademarks of MicroVision, Inc. in the United States and other countries. All other trademarks are the properties of their respective owners.
Non-GAAP information
To supplement MicroVision's condensed financial statements presented in accordance with GAAP, the Company presents investors with the non-GAAP financial measures "adjusted EBITDA" and "adjusted Gross Profit." Adjusted EBITDA consists of GAAP net income (loss) excluding the impact of the following: interest income and interest expense; income tax expense; depreciation and amortization; bargain purchase gain; share-based compensation; and restructuring charges. Adjusted Gross Profit is calculated as GAAP gross profit before share-based compensation expense and the amortization of acquired intangibles included in cost of revenue.
MicroVision believes that the presentation of adjusted EBITDA and adjusted Gross Profit provides important supplemental information to management and investors regarding financial and business trends, provides consistency and comparability with MicroVision's past financial reports, and facilitates comparisons with other companies in the Company's industry, many of which use similar non-GAAP financial measures to supplement their GAAP results. Internally, management uses these non-GAAP measures when evaluating operating performance because the exclusion of the items described above provides an additional useful measure of the Company's operating results and facilitates comparisons of the Company's core operating performance against prior periods and its business objectives. Externally, the Company believes that adjusted EBITDA and adjusted Gross Profit are useful to investors in their assessment of MicroVision's operating performance and the valuation of the Company.
Adjusted EBITDA and adjusted Gross Profit are not calculated in accordance with GAAP, and should be considered supplemental to, and not as a substitute for, or superior to, financial measures calculated in accordance with GAAP. Non-GAAP financial measures have limitations in that they do not reflect all of the costs associated with the operations of MicroVision's business as determined in accordance with GAAP. The Company expects to continue to incur expenses similar to the non-GAAP adjustments described above, and exclusion of these items from its non-GAAP financial measures should not be construed as an inference that these costs are unusual or infrequent.
The Company compensates for limitations of the adjusted EBITDA measure by prominently disclosing GAAP net income (loss), which the Company believes is the most directly comparable GAAP measure, and providing investors with a reconciliation from GAAP net income (loss) to adjusted EBITDA.
Similarly for Adjusted Gross Profit, the Company compensates for limitations of the measure by prominently disclosing GAAP gross profit which is the difference between Revenue and Cost of revenue, which the Company believes is the most directly comparable GAAP measure, and providing investors with a reconciliation by backing out share-based compensation expense and the amortization of acquired intangibles included in cost of revenue.
Forward-Looking Statements
Certain statements contained in this release, including customer engagement and the likelihood of success, opportunities for revenue and cash, expense reduction, market position, product portfolio, product and manufacturing capabilities, and expected revenue, expenses and cash usage are forward-looking statements that involve a number of risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. Factors that could cause actual results to differ materially from those projected in such forward-looking statements include the risk its ability to operate with limited cash or to raise additional capital when needed; market acceptance of its technologies and products or for products incorporating its technologies; the failure of its commercial partners to perform as expected under its agreements; its financial and technical resources relative to those of its competitors; its ability to keep up with rapid technological change; government regulation of its technologies; its ability to enforce its intellectual property rights and protect its proprietary technologies; the ability to obtain customers and develop partnership opportunities; the timing of commercial product launches and delays in product development; the ability to achieve key technical milestones in key products; dependence on third parties to develop, manufacture, sell and market its products; potential product liability claims; its ability to maintain its listing on The Nasdaq Stock Market, and other risk factors identified from time to time in the Company's SEC reports, including the Company's Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and other reports filed with the SEC. These factors are not intended to represent a complete list of the general or specific factors that may affect the Company. It should be recognized that other factors, including general economic factors and business strategies, may be significant, now or in the future, and the factors set forth in this release may affect the Company to a greater extent than indicated. Except as expressly required by federal securities laws, the Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, changes in circumstances or any other reason.
Investor Relations Contact
Jeff Christensen
Darrow Associates Investor Relations
MVIS@darrowir.com
Media Contact
Microvision, Inc.
Consolidated Balance Sheet
(In thousands)
(Unaudited)
| March 31, | December 31, | |||||||
| 2024 | 2023 | |||||||
Assets | ||||||||
Current Assets | ||||||||
Cash and cash equivalents | $ | 44,298 | $ | 45,167 | ||||
Investment securities, available-for-sale | 28,770 | 28,611 | ||||||
Restricted cash, current | 71 | 3,263 | ||||||
Accounts receivable, net of allowances | 1,121 | 949 | ||||||
Inventory | 3,738 | 3,874 | ||||||
Other current assets | 4,302 | 4,890 | ||||||
Total current assets | 82,300 | 86,754 | ||||||
Property and equipment, net | 8,549 | 9,032 | ||||||
Operating lease right-of-us asset | 13,212 | 13,758 | ||||||
Restricted cash, net of current portion | 1,968 | 961 | ||||||
Intangible assets, net | 16,662 | 17,235 | ||||||
Other assets | 1,491 | 1,895 | ||||||
Total assets | $ | 124,182 | $ | 129,635 | ||||
Liabilities and Shareholders' Equity | ||||||||
Current Liabilities | ||||||||
Accounts payable | $ | 2,161 | $ | 2,271 | ||||
Accrued liabilities | 9,971 | 8,640 | ||||||
Accrued liability for Ibeo business combination | 2,969 | 6,300 | ||||||
Contract liabilities | 213 | 300 | ||||||
Current portion of operating lease liability | 2,167 | 2,323 | ||||||
Other current liabilities | 270 | 669 | ||||||
Total current liabilities | 17,751 | 20,503 | ||||||
Operating lease liability, net of current portion | 12,358 | 12,714 | ||||||
Other long-term liabilities | 270 | 614 | ||||||
Total liabilities | 30,379 | 33,831 | ||||||
Commitments and contingencies | ||||||||
Shareholders' Equity | ||||||||
Common stock at par value | 206 | 195 | ||||||
Additional paid-in capital | 885,119 | 860,765 | ||||||
Accumulated other comprehensive loss | 157 | 210 | ||||||
Accumulated deficit | (791,679 | ) | (765,366 | ) | ||||
Total shareholders' equity | 93,803 | 95,804 | ||||||
Total liabilities and shareholders' equity | $ | 124,182 | $ | 129,635 | ||||
MicroVision, Inc.
Consolidated Statement of Operations
(In thousands, except earnings per share data)
(Unaudited)
| Three months ended March 31, | ||||||||
| 2024 | 2023 | |||||||
Revenue | $ | 956 | $ | 782 | ||||
Cost of revenue | 1,277 | 544 | ||||||
Gross profit | (321 | ) | 238 | |||||
Research and development expense | 17,311 | 12,692 | ||||||
Sales, marketing, general and administrative expense | 9,078 | 8,737 | ||||||
Total operating expenses | 26,389 | 21,429 | ||||||
Loss from operations | (26,710 | ) | (21,191 | ) | ||||
Bargain purchase gain | - | 1,706 | ||||||
Other income, net | 631 | 639 | ||||||
Net loss before taxes | $ | (26,079 | ) | $ | (18,846 | ) | ||
Income tax expense | (234 | ) | (181 | ) | ||||
Net income (loss) | $ | (26,313 | ) | $ | (19,027 | ) | ||
Net income (loss) per share - basic and diluted | $ | (0.13 | ) | $ | (0.11 | ) | ||
Weighted-average shares outstanding - basic and diluted | 196,748 | 174,703 | ||||||
Microvision, Inc.
Consolidated Statement of Cash Flows
(In thousands)
(Unaudited)
| Three months ended March 31, | ||||||||
| 2024 | 2023 | |||||||
Cash flows from operating activities | ||||||||
Net loss | $ | (26,313 | ) | $ | (19,027 | ) | ||
Adjustments to reconcile net loss to | ||||||||
net cash used in operations | ||||||||
Depreciation and amortization | 1,800 | 2,524 | ||||||
Impairment of property and equipment | 13 | - | ||||||
Bargain purchase gain | - | (1,706 | ) | |||||
Share-based compensation expense | 3,743 | 2,949 | ||||||
Inventory write-down | 9 | 29 | ||||||
Net accretion of premium on short-term investments | (288 | ) | (396 | ) | ||||
Change in: | ||||||||
Accounts receivable | (172 | ) | (506 | ) | ||||
Contract assets | - | (192 | ) | |||||
Inventory | 102 | (87 | ) | |||||
Other current and non-current assets | 992 | 647 | ||||||
Accounts payable | (527 | ) | 1,629 | |||||
Accrued liabilities | 1,331 | 2,017 | ||||||
Contract liabilities and other current liabilities | (480 | ) | (711 | ) | ||||
Operating lease liabilities | (639 | ) | (669 | ) | ||||
Other long-term liabilities | (330 | ) | 17 | |||||
Net cash used in operating activities | (20,759 | ) | (13,482 | ) | ||||
Cash flows from investing activities | ||||||||
Sales of investment securities | 7,900 | 22,000 | ||||||
Purchases of investment securities | (7,805 | ) | (3,898 | ) | ||||
Purchases of property and equipment | (114 | ) | (615 | ) | ||||
Cash paid for Ibeo business combination | (3,263 | ) | (11,233 | ) | ||||
Net cash provided by (used in) investing activities | (3,282 | ) | 6,254 | |||||
Cash flows from financing activities | ||||||||
Principal payments under finance leases | - | (6 | ) | |||||
Proceeds from stock option exercises | 62 | - | ||||||
Net proceeds from issuance of common stock | 20,956 | 12,691 | ||||||
Net cash provided by financing activities | 21,018 | 12,685 | ||||||
Effect of exchange rate changes on cash and cash equivalents | (31 | ) | - | |||||
Net increase (decrease) in cash and cash equivalents | (3,054 | ) | 5,457 | |||||
Cash, cash equivalents and restricted cash at beginning of period | 49,391 | 21,954 | ||||||
Cash, cash equivalents and restricted cash at end of period | $ | 46,337 | $ | 27,411 | ||||
| The following table provides a reconciliation of the cash, cash equivalents, and restricted cash balances as of | ||||||||
March 31, 2024 and December 31, 2023: | ||||||||
| March 31, | December 31, | |||||||
| 2024 | 2023 | |||||||
Cash and cash equivalents | $ | 44,298 | $ | 45,167 | ||||
Restricted cash | 2,039 | 4,224 | ||||||
Cash, cash equivalents and restricted cash | 46,337 | 49,391 | ||||||
MicroVision, Inc.
Reconciliation of GAAP to Non-GAAP Measures
(In thousands, except earnings per share data)
(Unaudited)
| Three months ended March 31, | ||||||||
| 2024 | 2023 | |||||||
Reconciliation of Non-GAAP Gross Profit: | ||||||||
Gross Profit | $ | (321 | ) | $ | 238 | |||
Share-based compensation expense | - | - | ||||||
Amortization of acquired intangibles | 387 | 255 | ||||||
Adjusted Gross Profit | $ | 66 | $ | 493 | ||||
Reconciliation of Non-GAAP Loss: | ||||||||
GAAP Net loss | $ | (26,313 | ) | $ | (19,027 | ) | ||
Other Income/Expense,net | (631 | ) | (639 | ) | ||||
Income taxes | 234 | 181 | ||||||
Depreciation & amortization | 1,800 | 2,524 | ||||||
Bargain purchase gain | - | (1,706 | ) | |||||
Share-based compensation expense | 3,743 | 2,949 | ||||||
Restructuring costs | 2,474 | - | ||||||
Adjusted EBITDA | $ | (18,693 | ) | $ | (15,718 | ) | ||
SOURCE: MicroVision, Inc.
View the original press release on accesswire.com
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
About ACCESS Newswire
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
GA-ASI Mojave First UAS To Complete Battlefield Short Field Ops16.9.2026 19:30:00 CEST | Press release
Short Takeoff and Landing Aircraft Validates Austere Field Capabilities SAN DIEGO, CA / ACCESS Newswire / September 16, 2026 / General Atomics Aeronautical Systems (GA-ASI) and Hanwha Aerospace have completed the first-ever flight operations from a simulated battlefield by a medium altitude, long endurance uncrewed aircraft. The partners proved that the Mojave Short Takeoff and Landing aircraft, or Mojave STOL, could land at a tank and artillery live-fire range during simulated combat conditions and then take off again to continue the mission. "This demonstration showcased Mojave's ability to perform tactical missions that are representative of real battlefield requirements and challenges," said GA-ASI CEO Linden Blue. "Whether the user needs contested and austere battlefield operations, ISR, weapons delivery, Air-Launched Effects deployment, troop resupply, counter-UAS, or missions requiring short and unimproved roads for takeoff, our aircraft answer the bell." "This demonstration mar
Freedom Holding Corp. Named General Partner of the Salesforce FIDE World Championship Match 202616.9.2026 16:13:00 CEST | Press release
Partnership builds on Freedom's long-term support for international chess as Geneva prepares to host the historic Gukesh - Sindarov title match NEW YORK CITY, NY / ACCESS Newswire / September 16, 2026 / Freedom Holding Corp. (NASDAQ:FRHC) will serve as General Partner of the Salesforce FIDE World Championship Match 2026, continuing a long-standing partnership with the International Chess Federation (FIDE) spanning elite competition, education and chess development. Freedom's involvement in the 2026 World Championship follows several years of cooperation with FIDE. The company was General Partner of the 2023 World Championship Match in Astana and title sponsor of the 2024 FIDE World Rapid & Blitz Championships in New York, one of FIDE's flagship global events. It has also supported international competitions and initiatives focused on expanding access to chess, developing young talent and strengthening the wider chess ecosystem. Earlier this year, Freedom and FIDE further expanded their
Xenetic Biosciences and Santersus AG Announce Definitive Share Exchange Agreement to Create Global Leader in NET-Targeting Therapeutics16.9.2026 13:00:00 CEST | Press release
Transaction expected to create a Nasdaq-listed, multi-indication clinical-stage company focused on targeting neutrophil extracellular traps (NETs), a driver of disease across critical care, autoimmune disease, transplantation and oncology Union of two companies brings together Santersus' NucleoCapture® technology, designed to physically remove NETs from circulation, with Xenetic's DNase technology, designed to enzymatically degrade NETs in tissue Joint pipeline includes four first-in-class programs, including pivotal-stage programs in sepsis and systemic lupus erythematosus (SLE), both of which have received FDA Breakthrough Device Designation Companies to host Business Update Conference Call and Webcast Today, Wednesday, September 16th at 8:30 AM ET FRAMINGHAM, MA / ACCESS Newswire / September 16, 2026 / Xenetic Biosciences, Inc. (NASDAQ:XBIO) ("Xenetic"), a biopharmaceutical company advancing its Deoxyribonuclease ("DNase") technology, and Santersus AG ("Santersus"), a privately held
DataTracks Completes First Live GloBE Filing Cycle, Delivering Close to 500 Pillar Two Filings Across 10+ Jurisdictions16.9.2026 11:15:00 CEST | Press release
HMRC-authorised provider completes close to 500 Pillar Two filings, including more than 150 GIRs, for 160+ clients across 10+ jurisdictions WEYBRIDGE, GB / ACCESS Newswire / September 16, 2026 / DataTracks, recognised by HMRC as an authorised software provider supporting UK Pillar Two submissions, has completed its first live BEPS Pillar Two filing cycle, delivering close to 500 filings, including more than 150 GIRs, across 10+ jurisdictions for more than 160 clients. The milestone caps two decades of work in regulatory reporting. The cycle spanned GloBE Information Returns (GIR), domestic top-up tax returns under local QDMTT (Qualified Domestic Minimum Top-up Tax) regimes, UK Overseas Return Notifications (ORNs), and other jurisdiction-specific returns and notifications. Several jurisdictions in this cycle, including the Netherlands and Luxembourg, require similar notifications confirming where the GIR was filed centrally, under their own local terms. DataTracks filed each return dire
Hydrosat Unveils Osiris Constellation, The Future of Thermal Intelligence16.9.2026 08:00:00 CEST | Press release
Next-generation satellite constellation will combine high-resolution thermal imaging with broad-area coverage and daily revisit to support governments, businesses, and researchers worldwide. PARIS, FR / ACCESS Newswire / September 16, 2026 / Hydrosat, the leading provider of thermal infrared satellite data and AI-powered analytics, today announced Osiris, its next-generation Earth observation constellation designed to deliver wide-area, high resolution intelligence for water and food security, critical infrastructure, and national security missions. At the core of each Osiris satellite is Hydrosat's next-generation thermal infrared payload, developed to collect high-resolution thermal data across exceptionally wide areas. Operating across three longwave infrared bands, the payload will capture imagery at 25-meter native resolution over 160-kilometer to 340-kilometer swath widths, addressing one of Earth observation's biggest challenges between spatial detail and collection scale. This
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
